Stay updated on ZFN Therapeutic SB-318 in MPS I Clinical Trial
Sign up to get notified when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.

Latest updates to the ZFN Therapeutic SB-318 in MPS I Clinical Trial page
- Check3 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1; the page otherwise continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal HTML header and a Home button, indicating that access to the study record is blocked.SummaryDifference0.5%

- Check31 days agoChange DetectedThe study page now returns a 403 Forbidden error instead of the study details, indicating blocked access. The changes include a 403 header and the standard error page layout (header, navigation, and footer).SummaryDifference18%

- Check52 days agoChange DetectedRevision: v3.6.6 appears on the page, replacing v3.6.5; it indicates a small software update rather than an update to study information.SummaryDifference0.1%

- Check67 days agoChange DetectedThe update introduces official study documents and related metadata to the record, including the SAP and Study Protocol PDFs and taxonomy terms. This clarifies and broadens access to the study’s formal materials and associated results information.SummaryDifference50%

Stay in the know with updates to ZFN Therapeutic SB-318 in MPS I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.